BioCentury | Feb 19, 2007
Strategy

Intellect's new frame of mind

Intellect Neurosciences Inc. is picking up where Mindset BioPharmaceuticals Ltd. left off in 2002 when investor interest in Alzheimer's disease immunotherapies waned. That was right around the time a similar program from Elan Corp. plc...
Items per page:
1 - 1 of 1
BioCentury | Feb 19, 2007
Strategy

Intellect's new frame of mind

Intellect Neurosciences Inc. is picking up where Mindset BioPharmaceuticals Ltd. left off in 2002 when investor interest in Alzheimer's disease immunotherapies waned. That was right around the time a similar program from Elan Corp. plc...
Items per page:
1 - 1 of 1